Influence of Advanced Diagnostic Technologies on the Global Market for Hepatitis E Diagnostic Tests

The global hepatitis e diagnostic tests market is anticipated to grow at a CAGR of 5.67% during the forecast period (2024-2031). Serology-based assays detect antibodies such as IgM and IgG antibodies produced by the body in response to HEV infection. Nucleic Acid Amplification Tests (NAATs) identify the genetic material of a virus in blood or stool samples. HEV-specific antibodies have been identified in patient samples utilizing ELISA testing. POCTs are fast diagnostic tests that provide instant results. HEV antigens are identified in liver tissue samples using immunohistochemistry (IHC).The market’s growth is attributed to improved diagnostic technologies across the globe. 

Browse the full report description of “Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report by Disease Type (Serology Tests, Molecular Tests, Immunoassays, and Point-of-Care Tests), by Technology (Enzyme-Linked Immunosorbent Assay, Rapid Diagnostic Tests, Next-Generation Sequencing, and Nucleic Acid Amplification Tests) and by End User (Hospitals and Clinics, Diagnostic Laboratories, and Public Health Agencies and Research Institutions), Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/hepatitis-e-diagnostic-tests-market

Diagnostic technology advancements, such as more sensitive and specific immunoassays that include Elecsys Anti-HEV tests, contribute to market growth. These assays detect HEV infections accurately and promptly. For instance, in November 2023, Roche launched Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV) infections in countries accepting the CE mark. The elecsys Anti-HEV IgM and IgG immunoassays are used to identify acute or recently acquired HEV infections in human serum and plasma, in addition to IgM antibodies opposed to HEV in human serum and plasma.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Disease Type

o By Technology

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- includes Bio-Rad Laboratories, Inc., Danaher Corp., Diasorin S.p.A., EKF Diagnostics Holdings plc, ELITech Group, and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Hepatitis E Diagnostic Tests Market Report Segment

By Disease Type

• Serology Tests
• Molecular Tests
• Immunoassays
• Point-of-Care Tests

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests (RDTs)
• Next-Generation Sequencing (NGS)
• Nucleic Acid Amplification Tests (NAAT)

By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Public Health Agencies and Research Institutions

Global Hepatitis E Diagnostic Tests Market Report Segment by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hepatitis-e-diagnostic-tests-market